AT-010 (Amylon)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAT-010 (Amylon)
Drug Alias NameRNA-based therapy (Amylon)AT-010
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsAmyloidosisCerebral Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmylon Therapeutics Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmylon Therapeutics Bv
Active IndicationsN/A
Inactive IndicationsAmyloidosisCerebral Hemorrhage

Other Information

ATC CodeN/A
Related LinksN/A